4-1BB signal stimulates the activation, expansion, and effector functions of γδ T cells in mice and humans-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

4-1BB signal stimulates the activation, expansion, and effector functions of γδ T cells in mice and humans

Published:2013-06-12 Issue:7 Volume:43 Page:1839-1848
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Lee Seung J.,Kim Young H.¹,Hwang Sun H.¹,Kim Yu. I.¹,Han In S.²,Vinay Dass S.³,Kwon Byoung S.

Affiliation:

1. Immune & Cell Therapy Branch; National Cancer Center; Ilsan; Gyeonggi-do; Korea

2. Department of Biological Sciences; University of Ulsan; Ulsan; Korea

3. Section of Clinical Immunology; Department of Medicine, Tulane University Health Sciences Center; New Orleans; LA; USA

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/eji.201242842/fullpdf

Reference50 articles.

1. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity;Croft;Nat. Rev. Immunol.,2003

2. TNF/TNFR family members in costimulation of T cell responses;Watts;Annu. Rev. Immunol.,2005

3. TNF superfamily: costimulation and clinical applications;Vinay;Cell. Biol. Int.,2009

4. Role of 4-1BB in immune responses;Vinay;Semin. Immunol.,1998

5. 4-1BB is expressed on CD45RAhiROhi transitional T cell in humans;Garni-Wagner;Cell. Immunol.,1996

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD137 expression and signal function drive pleiotropic γδ T-cell effector functions that inhibit intracellular M. tuberculosis growth;Clinical Immunology;2024-09

2. Advancements in γδT cell engineering: paving the way for enhanced cancer immunotherapy;Frontiers in Immunology;2024-03-21

3. Challenges and new technologies in adoptive cell therapy;Journal of Hematology & Oncology;2023-08-18

4. Releasing the restraints of Vγ9Vδ2 T-cells in cancer immunotherapy;Frontiers in Immunology;2023-01-13

5. CD137 (4-1BB)-Based Cancer Immunotherapy on Its 25th Anniversary;Cancer Discovery;2022-12-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3